Atlas Trials

Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole

Clinical trial NCT01259115 · COMPLETED

Trial details

NCT number
NCT01259115
Sponsor
Purdue Pharma LP
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2002-10-01
Primary completion
2003-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.